Clinical Trials Directory

Trials / Completed

CompletedNCT00846001

Resynchronization Surgery Combined Unified Efficacy

Study of Resynchronization and CABG Unified Efficacy in Ischemic Heart Failure Patients

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
178 (actual)
Sponsor
Meshalkin Research Institute of Pathology of Circulation · Network
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to compare survivability and efficacy of the patients with severe ischemic heart failure after coronary artery bypass grafting alone and coronary artery bypass grafting with single-step implantation of CRT system (CABG alone vs CABG + CRT )

Conditions

Interventions

TypeNameDescription
PROCEDURECoronary artery bypass graftingStandard coronary surgry according guidelines
DEVICEEpicardial implantation of cardiac resynchronization therapy deviceDuring the cardiac surgery, the CABG+CRT arm patients will be implanted with epicardial leads to the right atrium, right and left ventricles. Left ventricle leads will be fixed to the posterolateral wall provided that there is no scar or fat tissue (behind and 2-3 cm apical than obtuse marginal artery). Right atrial and right ventricular leads will be fixed in a traditional way. Then the leads will be guided into a preformed pocket (left subclavian region) and connected with the CRT device.

Timeline

Start date
2007-09-01
Primary completion
2010-09-01
Completion
2010-09-01
First posted
2009-02-18
Last updated
2015-07-15

Locations

3 sites across 3 countries: Poland, Russia, Slovenia

Source: ClinicalTrials.gov record NCT00846001. Inclusion in this directory is not an endorsement.